Jignesh Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jignesh Patel has a total of 340 co-authors. Here are the top co-authors by number of shared publications:
- Jon A. Kobashigawa
Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, United States
48 shared publications Michelle Kittleson
Department of Cardiology, Smidt Heart Institute, Cedars‐Sinai Medical Center, Los Angeles, California, USA
16 shared publications- Evan P. Kransdorf
Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
15 shared publications - Michelle M. Kittleson
Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (M.M.K.).
15 shared publications David Chang
Department of Cardiology, Smidt Heart Institute, Cedars‐Sinai Medical Center, Los Angeles, California, USA
12 shared publicationsLawrence Czer
Smidt Cedars‐Sinai Heart Institute Los Angeles CA USA
11 shared publications
Latest Publications
- 1 September 2025
- Published by Springer Nature
- p. 387-394
Quality-of-Life After Heart Transplantation
- 1 September 2025
- Published by Springer Nature
- p. 395-399
Patient Selection in the Context of Organ Scarcity
- 1 September 2025
- Published by Springer Nature
- p. 395-399
Patient Selection in the Context of Organ Scarcity
- 1 September 2025
- Published by Springer Nature
- p. 75-91
The Sensitized Patient Awaiting Heart Transplantation
- 1 September 2025
- Published by Springer Nature
- p. 75-91
The Sensitized Patient Awaiting Heart Transplantation
- 1 September 2025
- Published by Springer Nature
- p. 139-161
Maintenance Immunosuppression Strategies in Heart Transplantation
- 1 September 2025
- Published by Springer Nature
- p. 139-161
Maintenance Immunosuppression Strategies in Heart Transplantation
- Open Access
- 1 January 2025
- Published by BMJ in Open Heart
- Vol. 12 (1) , e003120
Ratio of interventricular septal thickness to global longitudinal strain accurately identifies cardiac amyloidosis
Objectives: Conventional transthoracic echocardiographic measurements like global longitudinal strain (GLS) have shown promise in distinguishing cardiac amyloidosis (CA), but with limited specificity. We investigated the performance of common echo measurements, GLS, and their combinations in discriminating CA from an undifferentiated cohort with increased left ventricular wall thickness. Methods: We conducted a retrospective single-centre case–control study of 876 echos from 232 patients with CA and 1325 echos from 279 patients who underwent pyrophosphate scintigraphy but had CA definitively ruled out. Common echo measurements were collected and additional GLS measurements were performed post hoc. We reported discrimination performance with the area under the receiver operating characteristic curve (AUC) and associated sensitivity, specificity and positive predictive value at the optimal threshold. Results: We found that the ratio of end-diastolic interventricular septal thickness (IVSd) to GLS had the highest performance in differentiating CA with an AUC of 0.812. At the optimal threshold of >0.15, IVSd/GLS had a sensitivity of 0.70 and specificity of 0.80 for CA. Other measurements and ratios, including the ratio of left ventricular ejection fraction to GLS (AUC 0.682), had lower performance when evaluated against a suspicious control cohort with increased left ventricular wall thickness. Conclusion: If validated in prospective multi-centre studies, the routine measurement of IVSd/GLS can assist with earlier diagnosis of CA, resulting in earlier initiation of treatment in this underserved population.
- 1 January 2025
- Published by BMJ in Open Heart
- Vol. 12 (1) , e003120
Open AccessRatio of interventricular septal thickness to global longitudinal strain accurately identifies cardiac amyloidosis
Objectives: Conventional transthoracic echocardiographic measurements like global longitudinal strain (GLS) have shown promise in distinguishing cardiac amyloidosis (CA), but with limited specificity. We investigated the performance of common echo measurements, GLS, and their combinations in discriminating CA from an undifferentiated cohort with increased left ventricular wall thickness. Methods: We conducted a retrospective single-centre case–control study of 876 echos from 232 patients with CA and 1325 echos from 279 patients who underwent pyrophosphate scintigraphy but had CA definitively ruled out. Common echo measurements were collected and additional GLS measurements were performed post hoc. We reported discrimination performance with the area under the receiver operating characteristic curve (AUC) and associated sensitivity, specificity and positive predictive value at the optimal threshold. Results: We found that the ratio of end-diastolic interventricular septal thickness (IVSd) to GLS had the highest performance in differentiating CA with an AUC of 0.812. At the optimal threshold of >0.15, IVSd/GLS had a sensitivity of 0.70 and specificity of 0.80 for CA. Other measurements and ratios, including the ratio of left ventricular ejection fraction to GLS (AUC 0.682), had lower performance when evaluated against a suspicious control cohort with increased left ventricular wall thickness. Conclusion: If validated in prospective multi-centre studies, the routine measurement of IVSd/GLS can assist with earlier diagnosis of CA, resulting in earlier initiation of treatment in this underserved population.
- 18 July 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (7) , e15403
Importance of Transplant Era on Post–Heart Transplant Predictive Models: A UNOS Cohort Analysis
Background: The application of posttransplant predictive models is limited by their poor statistical performance. Neglecting the dynamic evolution of demographics and medical practice over time may be a key issue.Objectives: Our objective was to develop and validate era‐specific predictive models to assess whether these models could improve risk stratification compared to non–era‐specific models.Methods: We analyzed the United Network for Organ Sharing (UNOS) database including first noncombined heart transplantations (2001–2018, divided into four transplant eras: 2001–2005, 2006–2010, 2011–2015, 2016–2018). The endpoint was death or retransplantation during the 1st‐year posttransplant. We analyzed the dynamic evolution of major predictive variables over time and developed era‐specific models using logistic regression. We then performed a multiparametric evaluation of the statistical performance of era‐specific models and compared them to non–era‐specific models in 1000 bootstrap samples (derivation set, 2/3; test set, 1/3).Results: A total of 34 738 patients were included, 3670 patients (10.5%) met the composite endpoint. We found a significant impact of transplant era on baseline characteristics of donors and recipients, medical practice, and posttransplant predictive models, including significant interaction between transplant year and major predictive variables (total serum bilirubin, recipient age, recipient diabetes, previous cardiac surgery). Although the discrimination of all models remained low, era‐specific models significantly outperformed the statistical performance of non–era‐specific models in most samples, particularly concerning discrimination and calibration.Conclusions: Era‐specific models achieved better statistical performance than non–era‐specific models. A regular update of predictive models may be considered if they were to be applied for clinical decision‐making and allograft allocation.
- 18 July 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (7) , e15403
Importance of Transplant Era on Post–Heart Transplant Predictive Models: A UNOS Cohort Analysis
Background: The application of posttransplant predictive models is limited by their poor statistical performance. Neglecting the dynamic evolution of demographics and medical practice over time may be a key issue.Objectives: Our objective was to develop and validate era‐specific predictive models to assess whether these models could improve risk stratification compared to non–era‐specific models.Methods: We analyzed the United Network for Organ Sharing (UNOS) database including first noncombined heart transplantations (2001–2018, divided into four transplant eras: 2001–2005, 2006–2010, 2011–2015, 2016–2018). The endpoint was death or retransplantation during the 1st‐year posttransplant. We analyzed the dynamic evolution of major predictive variables over time and developed era‐specific models using logistic regression. We then performed a multiparametric evaluation of the statistical performance of era‐specific models and compared them to non–era‐specific models in 1000 bootstrap samples (derivation set, 2/3; test set, 1/3).Results: A total of 34 738 patients were included, 3670 patients (10.5%) met the composite endpoint. We found a significant impact of transplant era on baseline characteristics of donors and recipients, medical practice, and posttransplant predictive models, including significant interaction between transplant year and major predictive variables (total serum bilirubin, recipient age, recipient diabetes, previous cardiac surgery). Although the discrimination of all models remained low, era‐specific models significantly outperformed the statistical performance of non–era‐specific models in most samples, particularly concerning discrimination and calibration.Conclusions: Era‐specific models achieved better statistical performance than non–era‐specific models. A regular update of predictive models may be considered if they were to be applied for clinical decision‐making and allograft allocation.
- 10 May 2024
- Published by Morressier GmbH
Improved Health-Related Quality of Life in Acoramidis-Treated Patients with ATTR-CM, Demonstrated by Improvements in KCCQ Scores PC125 (#295)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 10 May 2024
- Published by Morressier GmbH
Improved Health-Related Quality of Life in Acoramidis-Treated Patients with ATTR-CM, Demonstrated by Improvements in KCCQ Scores PC125 (#295)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 21 January 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (3) , 578-580
Prevalence and Treatment of Atrial Fibrillation and Flutter in Cardiac Amyloidosis
- 21 January 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (3) , 578-580
Prevalence and Treatment of Atrial Fibrillation and Flutter in Cardiac Amyloidosis
- 30 October 2023
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 30 (5) , 669-678
The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology
- 30 October 2023
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 30 (5) , 669-678
The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology
- Open Access
Utility of a Score-Based Approach to Liver Assessment in Heart Transplant Candidates
Background: While abnormalities of liver function and imaging are common in patients with end-stage heart failure, advanced fibrosis is uncommon. Liver biopsy (LB) is used to identify advanced fibrosis in heart transplant (HT) candidates but can delay or limit access to definitive therapies and cause complications. We sought to develop and determine the utility of a clinical risk score for advanced fibrosis in HT candidates. Methods: We conducted a retrospective, single-center review of patients evaluated for HT between 2012 and 2019 (n = 1,651) and identified those who underwent LB (n = 137) as well as a matched control cohort (n = 160). All biopsies were reviewed by a liver pathologist. Kaplan-Meir curves were used to assess survival. Univariate logistic modeling was used to identify factors predictive of advanced liver fibrosis. Simulation using synthetic data bootstraps was performed to determine the utility of using a score-based approach to trigger LB. Results: We identified 32 (23%) patients with stage 0, 79 (58%) with stage 1-2, and 26 (19%) with stage 3-4/advanced fibrosis. We found no difference in survival at 3 years post-HT based on pre-HT fibrosis stage. The factor most associated with pursuit of LB was abnormal liver parenchyma on ultrasound. We found that a score combining severe tricuspid regurgitation, alcohol use, and low-density lipoprotein improved specificity and reduced the number of LBs required. Conclusions: A score composed of non-invasive factors may help reduce the number of patients who require LB for diagnosis of advanced fibrosis. Additional multicenter studies are needed to validate this score.
Open AccessUtility of a Score-Based Approach to Liver Assessment in Heart Transplant Candidates
Background: While abnormalities of liver function and imaging are common in patients with end-stage heart failure, advanced fibrosis is uncommon. Liver biopsy (LB) is used to identify advanced fibrosis in heart transplant (HT) candidates but can delay or limit access to definitive therapies and cause complications. We sought to develop and determine the utility of a clinical risk score for advanced fibrosis in HT candidates. Methods: We conducted a retrospective, single-center review of patients evaluated for HT between 2012 and 2019 (n = 1,651) and identified those who underwent LB (n = 137) as well as a matched control cohort (n = 160). All biopsies were reviewed by a liver pathologist. Kaplan-Meir curves were used to assess survival. Univariate logistic modeling was used to identify factors predictive of advanced liver fibrosis. Simulation using synthetic data bootstraps was performed to determine the utility of using a score-based approach to trigger LB. Results: We identified 32 (23%) patients with stage 0, 79 (58%) with stage 1-2, and 26 (19%) with stage 3-4/advanced fibrosis. We found no difference in survival at 3 years post-HT based on pre-HT fibrosis stage. The factor most associated with pursuit of LB was abnormal liver parenchyma on ultrasound. We found that a score combining severe tricuspid regurgitation, alcohol use, and low-density lipoprotein improved specificity and reduced the number of LBs required. Conclusions: A score composed of non-invasive factors may help reduce the number of patients who require LB for diagnosis of advanced fibrosis. Additional multicenter studies are needed to validate this score.